A 65-year-old man is hospitalized in the intensive care unit for management of severe seps… — USMLE Step 3

A 65-year-old man is hospitalized in the intensive care unit for management of severe sepsis secondary to pneumonia. He was started on prophylactic subcutaneous unfractionated heparin upon admission. On hospital day 6, his platelet count drops precipitously from a baseline of $260,000/\text{mm}^3$ to $85,000/\text{mm}^3$ . He has no evidence of active bleeding. Physical examination reveals a new, swollen, and tender right calf. A presumptive clinical diagnosis of heparin-induced thrombocytopenia (HIT) with thrombosis is made. All heparin products are immediately discontinued, and a continuous intravenous infusion of argatroban is ordered.

Which of the following monitoring and treatment evaluation steps are strictly indicated in the ongoing management of this patient? (Select all that apply)

Titrate the argatroban infusion to maintain the activated partial thromboplastin time (aPTT) at $1.5$ to $3.0$ times the patient's baseline value.Cevap
Assess the platelet count daily to ensure recovery to greater than $150,000/\text{mm}^3$ prior to transitioning to an oral vitamin K antagonist.Cevap
C
Initiate oral warfarin therapy immediately to overlap with argatroban and expedite the transition to outpatient management.
D
Order a prophylactic platelet transfusion to maintain the platelet count above $100,000/\text{mm}^3$ and prevent spontaneous hemorrhage.
E
Delay the initiation of argatroban until a serotonin release assay (SRA) returns positive to definitively confirm the diagnosis.

Cevap

The correct steps are to titrate the argatroban infusion to maintain the aPTT at 1.5 to 3.0 times the patient's baseline value, and to assess the platelet count daily to ensure recovery to greater than 150,000/mm³ prior to transitioning to an oral vitamin K antagonist.

The appropriate management of acute HIT requires anticoagulation with a non-heparin agent such as argatroban. Argatroban is administered as a continuous intravenous infusion and requires frequent monitoring and titration of the activated partial thromboplastin time (aPTT) to a target of 1.5 to 3.0 times the baseline value. Furthermore, the hallmark of HIT resolution is the normalization of the platelet count. Platelets must be monitored daily; transitioning to an oral vitamin K antagonist (warfarin) is strictly contraindicated until the platelet count has recovered to >150,000/mm³ due to the risk of venous limb gangrene.

Adım Adım Çözüm

Analyze the clinical scenario to confirm the diagnosis and current phase of treatment.

The patient has a high clinical probability of Heparin-Induced Thrombocytopenia (HIT) complicated by deep vein thrombosis. Heparin has been appropriately stopped and argatroban initiated.

Establishing the acute phase of HIT dictates both the immediate pharmacologic requirements and the absolute contraindications.

Identify the required monitoring parameters for the newly initiated pharmacotherapy (argatroban).

Argatroban is a direct thrombin inhibitor that must be continuously titrated using the activated partial thromboplastin time (aPTT).

Direct thrombin inhibitors have a narrow therapeutic index; maintaining the aPTT at 1.5 to 3.0 times baseline prevents both thrombosis propagation and iatrogenic bleeding.

Determine the necessary evaluations to monitor disease resolution and guide future therapy transitions.

Daily platelet counts must be monitored until they recover to >150,000/mm³.

Platelet recovery indicates the cessation of the antibody-mediated platelet activation, which is the prerequisite for safely introducing warfarin.

Evaluate the remaining options to avoid contraindicated interventions.

Warfarin initiation and platelet transfusions are identified as contraindicated, and delaying treatment for confirmatory testing is deemed dangerous.

Warfarin causes venous limb gangrene in acute HIT, platelet transfusions fuel thrombosis, and waiting for an SRA delays life-saving anticoagulation.

Anahtar Kavram

Management of Heparin-Induced Thrombocytopenia (HIT) requires immediate cessation of heparin, initiation of a non-heparin anticoagulant (e.g., argatroban) monitored via aPTT, daily platelet tracking, and strict avoidance of warfarin or platelet transfusions until the platelet count has fully recovered.

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru